Triple
T4061283
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | National Center for Toxicological Research |
E86215
|
entity |
| Predicate | supportsRegulationBy |
P53832
|
FINISHED |
| Object | U.S. Food and Drug Administration |
E13297
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Food and Drug Administration | Statement: [National Center for Toxicological Research, supportsRegulationBy, U.S. Food and Drug Administration]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Context triple: [National Center for Toxicological Research, supportsRegulationBy, U.S. Food and Drug Administration]
-
A.
Food and Drug Administration
chosen
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
B.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
C.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
D.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
E.
FDA CFSAN
FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: supportsRegulationBy Context triple: [National Center for Toxicological Research, supportsRegulationBy, U.S. Food and Drug Administration]
-
A.
supportsRegulation
Indicates that one entity endorses, backs, or advocates for the implementation or continuation of a specific regulation.
-
B.
allowsRegulationOf
Indicates that one entity grants the authority, means, or conditions for another entity to control, manage, or govern something.
-
C.
hasRegulations
Indicates that one entity imposes, contains, or is associated with rules or regulatory requirements that govern the behavior or operation of another entity.
-
D.
subjectToRegulation
Indicates that an entity is governed, constrained, or controlled by a specific rule, law, or regulatory framework.
-
E.
supportedRegime
Indicates that an entity provided assistance, endorsement, or backing to a particular political regime or government in power.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69aed93c69208190a4efac0efe3cd69b |
completed | March 9, 2026, 2:29 p.m. |
| NER | Named-entity recognition | batch_69aefd0bdea48190805a79515ee92709 |
completed | March 9, 2026, 5:02 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b589d11b0881909984a0b4f738b444 |
completed | March 14, 2026, 4:16 p.m. |
| PD | Predicate disambiguation | batch_69aef90438908190a005b08ba271eacf |
completed | March 9, 2026, 4:44 p.m. |
| PDg | Predicate description generation | batch_69aefd0995188190b1bc8771fe7f423a |
completed | March 9, 2026, 5:02 p.m. |
Created at: March 9, 2026, 3:38 p.m.